Jefferies Financial Group Inc.
Position in LFCR — Lifecore Biomedical, Inc. De
CIK 96223
NEW YORK, NY
Position in LFCR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$120,900
+$21,603 QoQ
Shares Held
32,500
+73.8% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $24,089,483 across 13 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
|
370,092 | $9,389,234 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,697 | $3,628,635 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
293,670 | $2,325,866 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
10,630 | $1,791,580 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,304 | $1,534,899 | |
| 6 | ZTS |
Zoetis Inc.
|
18,525 | $1,331,206 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
34,027 | $1,231,777 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
27,400 | $991,880 |
All Filings in LFCR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $120,900 | 32,500 | Shares | Defined | 2026-05-08 | |
| 2024-03-31 | $99,297 | 18,700 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $109,563 | 17,700 | Shares | Defined | 2024-05-06 | |
| 2023-09-30 | $133,635 | 17,700 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||